Get the Stockscreener App
69.97
1.63%
1.12
Pre-market:
71.06
1.09
+1.56%
Tempus Ai Inc stock is traded at $69.97, with a volume of 7.56M.
It is up +1.63% in the last 24 hours and up +34.30% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$68.85
Open:
$68.79
24h Volume:
7.56M
Relative Volume:
1.20
Market Cap:
$12.70B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-40.72
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
+14.18%
1M Performance:
+34.30%
6M Performance:
+37.52%
1Y Performance:
-19.61%
1-Day Range:
$68.42
$71.48
1-Week Range:
$57.72
$71.48
52-Week Range:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
69.97 | 10.71B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
264.90 | 42.48B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
58.96 | 11.62B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
72.68 | 8.94B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
96.00 | 7.96B | 1.34B | 230.70M | 440.96M | 2.6695 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Tempus AI Stock (TEM) Opinions on Recent Chart Setups and Price Targets - Quiver Quantitative
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
Tempus AI Stock Price: TEM Stock Chart, Market Cap & News Today - CoinGecko
TEM Stock Slips Overnight: CEO-Linked $9.6M Share Sale Puts A Cloud Over 'AI As Physician' Story - Stocktwits
H.C. Wainwright raises Tempus AI stock price target to $66 By Investing.com - Investing.com Australia
Best Artificial Intelligence Stocks To ConsiderSeptember 11th - MarketBeat
Tempus Launches Effort to Build the Largest Multimodal Whole-Genome Dataset to Advance AI-Driven Healthcare Innovation - 01net
Tempus AI, Inc. Launches Effort To Build The Largest Multimodal Whole-Genome Dataset To Advance AI-Driven Healthcare Innovation - marketscreener.com
Tempus AI Building Multimodal Whole-Genome Dataset for AI Research - marketscreener.com
Tempus AI plans 100,000 whole genome sequencing dataset - investing.com
Nvidia, Snowflake, Chubb And A Health Care Stock On CNBC’s ‘Final Trades’ - Benzinga
Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
TEM Maintained by HC Wainwright & Co. -- Price Target Raised to $66.00 - GuruFocus
H.C. Wainwright raises Tempus AI stock price target to $66 - investing.com
Tempus AI, Inc. • Robinhood Token (TEM) Price Prediction for 2026 to 2031 - Bybit
Top Artificial Intelligence Stocks To ResearchSeptember 10th - MarketBeat
Tracking Cathie Wood: Loading Up on Gene-Editing BEAM、NTLA, Trimming Googl and Tempus AI - Moomoo
Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agent - Bitget
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology - 01net
Top Artificial Intelligence Stocks To Follow NowSeptember 9th - MarketBeat
UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group - MarketBeat
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - Stocktwits
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral - investing.com
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI - CryptoRank
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks? - Kalkine Media
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc. - MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating Volatility With A 21.6% Revenue Growth - DirectorsTalk Interviews
Tracking Cathie Wood: Loading Up on Gene Editing and Precision Medicine, Trimming Tempus AI and Synthetic Biology - Moomoo
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM - MarketBeat
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum - quiverquant.com
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
Tempus AI Director Jennifer A. Doudna Sells 676 Shares Under Rule 10b5-1 Plan - Kalkine Media
Tempus AI Data CEO Ryan Fukushima's Spouse Executes $30,846 Share Sale via 10b5-1 Plan - Kalkine Media
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan - Stock Titan
Tempus AI (TEM) director’s stock sale follows preset plan - Stock Titan
Tempus AI (TEM) director sells 676 shares under preset plan - Stock Titan
Artificial Intelligence Stocks Worth WatchingSeptember 3rd - MarketBeat
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? - finance.yahoo.com
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says - Benzinga
Cantor Fitzgerald initiates Tempus AI stock with overweight rating By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Watch TodaySeptember 2nd - MarketBeat
Tempus AI gains as Cantor issues new Overweight on Data and applications segment - Seeking Alpha
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 - The Motley Fool
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
2.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):